BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9846644)

  • 1. Potentiation of adenosine A1 receptor-mediated inositol phospholipid hydrolysis by tyrosine kinase inhibitors in CHO cells.
    Dickenson JM; Hill SJ
    Br J Pharmacol; 1998 Nov; 125(5):1049-57. PubMed ID: 9846644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human adenosine A1 receptor and P2Y2-purinoceptor-mediated activation of the mitogen-activated protein kinase cascade in transfected CHO cells.
    Dickenson JM; Blank JL; Hill SJ
    Br J Pharmacol; 1998 Aug; 124(7):1491-9. PubMed ID: 9723963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic interactions between human transfected adenosine A1 receptors and endogenous cholecystokinin receptors in CHO cells.
    Dickenson JM; Hill SJ
    Eur J Pharmacol; 1996 Apr; 302(1-3):141-51. PubMed ID: 8791002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfected adenosine A1 receptor-mediated modulation of thrombin-stimulated phospholipase C and phospholipase A2 activity in CHO cells.
    Dickenson JM; Hill SJ
    Eur J Pharmacol; 1997 Feb; 321(1):77-86. PubMed ID: 9083789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of G-protein betagamma subunits in coupling the adenosine A1 receptor to phospholipase C in transfected CHO cells.
    Dickenson JM; Hill SJ
    Eur J Pharmacol; 1998 Aug; 355(1):85-93. PubMed ID: 9754942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy between the inositol phosphate responses to transfected human adenosine A1-receptors and constitutive P2-purinoceptors in CHO-K1 cells.
    Megson AC; Dickenson JM; Townsend-Nicholson A; Hill SJ
    Br J Pharmacol; 1995 Aug; 115(8):1415-24. PubMed ID: 8564200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of p42/p44 MAPK and p38 MAPK by the adenosine A(1) receptor in DDT(1)MF-2 cells.
    Robinson AJ; Dickenson JM
    Eur J Pharmacol; 2001 Feb; 413(2-3):151-61. PubMed ID: 11226388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of protein kinase B by the A(1)-adenosine receptor in DDT(1)MF-2 cells.
    Germack R; Dickenson JM
    Br J Pharmacol; 2000 Jun; 130(4):867-74. PubMed ID: 10864894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of GABAA receptor function by tyrosine kinase inhibitors and their inactive analogues.
    Dunne EL; Moss SJ; Smart TG
    Mol Cell Neurosci; 1998 Nov; 12(4-5):300-10. PubMed ID: 9828093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A1 and A2 adenosine receptor modulation of contractility in the cauda epididymis of the guinea-pig.
    Haynes JM; Alexander SP; Hill SJ
    Br J Pharmacol; 1998 Oct; 125(3):570-6. PubMed ID: 9806342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human 5-HT1B receptor stimulated inositol phospholipid hydrolysis in CHO cells: synergy with Gq-coupled receptors.
    Dickenson JM; Hill SJ
    Eur J Pharmacol; 1998 May; 348(2-3):279-85. PubMed ID: 9652344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of tyrosine kinase inhibitors on volume-sensitive chloride current in human atrial myocytes: evidence for dual regulation by Src and EGFR kinases.
    Du XL; Gao Z; Lau CP; Chiu SW; Tse HF; Baumgarten CM; Li GR
    J Gen Physiol; 2004 Apr; 123(4):427-39. PubMed ID: 15024039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats.
    Blair HC; Jordan SE; Peterson TG; Barnes S
    J Cell Biochem; 1996 Jun; 61(4):629-37. PubMed ID: 8806087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonselective effects of the putative phospholipase C inhibitor, U73122, on adenosine A1 receptor-mediated signal transduction events in Chinese hamster ovary cells.
    Walker EM; Bispham JR; Hill SJ
    Biochem Pharmacol; 1998 Dec; 56(11):1455-62. PubMed ID: 9827577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine A1 receptor-dependent and -independent effects of the allosteric enhancer PD 81,723.
    Musser B; Mudumbi RV; Liu J; Olson RD; Vestal RE
    J Pharmacol Exp Ther; 1999 Feb; 288(2):446-54. PubMed ID: 9918544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of p42/p44 mitogen-activated protein kinase by the human adenosine A3 receptor in transfected CHO cells.
    Graham S; Combes P; Crumiere M; Klotz KN; Dickenson JM
    Eur J Pharmacol; 2001 May; 420(1):19-26. PubMed ID: 11412835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of protein tyrosine kinase inhibitors on contractility of isolated bronchioles of the rat.
    Chopra LC; Hucks D; Twort CH; Ward JP
    Am J Respir Cell Mol Biol; 1997 Apr; 16(4):372-8. PubMed ID: 9115747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine kinase inhibitors suppress prostaglandin F2alpha-induced phosphoinositide hydrolysis, Ca2+ elevation and contraction in iris sphincter smooth muscle.
    Yousufzai SY; Abdel-Latif AA
    Eur J Pharmacol; 1998 Nov; 360(2-3):185-93. PubMed ID: 9851585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of tyrosine phosphorylation in the positive inotropic effect produced by H(1)-receptors with histamine in guinea-pig left atrium.
    Akaishi Y; Hattori Y; Yoshimoto K; Kitabatake A; Yasuda K; Kanno M
    Br J Pharmacol; 2000 Jun; 130(4):907-15. PubMed ID: 10864899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase C-mediated inhibition of transmembrane signalling through CCK(A) and CCK(B) receptors.
    Smeets RL; Fouraux MA; van Emst-de Vries SE; De Pont JJ; Willems PH
    Br J Pharmacol; 1998 Mar; 123(6):1189-97. PubMed ID: 9559904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.